早发型面肩肱型肌营养不良症运动功能的多国研究
该多国研究在12个合作国际神经肌肉研究组中心收集52例早发型FSHD1型患者的标准化运动评估,发现面部无力起病年龄越早与临床严重度评分越高、计时功能测试速度越慢及徒手肌力测试评分越低相关,需要纵向评估确定疾病进展速率。
要点
- 早发型FSHD1型患者中,面部无力起病年龄越早与临床严重度评分越高相关。
- 面部无力起病年龄越早与计时功能测试速度越慢及徒手肌力测试评分越低相关。
- 研究观察到早发型FSHD临床变异显著,需纵向评估确定疾病进展速率。
核心结论
- 早发型FSHD存在显著临床变异,面部无力起病年龄越早与疾病严重度越高相关,需纵向评估确定该人群疾病进展速率。
研究设计与样本
- 在12个合作国际神经肌肉研究组中心收集52例10岁前出现无力的早发型FSHD1型参与者的标准化运动评估,采用线性回归模型分析年龄、性别和D4Z4重复序列与运动功能的关联。
主要发现
- 52例参与者中女性占60%,平均年龄22.9±14.7岁,无力在肩部和腹部肌肉最为明显。
- 入组年龄越大与临床严重度评分越高相关(p=0.003)。
- 调整入组年龄、性别和D4Z4重复序列后,面部无力起病年龄越早与临床严重度评分越高、计时功能测试速度越慢及徒手肌力测试评分越低相关(p<0.05)。
局限性
- 原文结论指出需要纵向评估以确定该人群的疾病进展速率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate motor function associations with age, sex, and D4Z4 repeats among participants with early-onset facioscapulohumeral muscular dystrophy (FSHD) type 1 as defined by weakness onset before 10 years of age. METHODS: We collected standardized motor assessments, including manual muscle testing (MMT), quantitative muscle testing, functional motor evaluations, and clinical severity scores (CSSs), at 12 Cooperative International Neuromuscular Research Group centers. To measure associations, we used linear regression models adjusted for sex, evaluation age, age at onset of weakness, and D4Z4 repeats. RESULTS: Among 52 participants (60% female, mean age 22.9 ± 14.7 years), weakness was most pronounced in the shoulder and abdominal musculature. Older enrollment age was associated with greater CSSs (p = 0.003). When adjusted for enrollment age, sex, and D4Z4 repeats, younger age at onset of facial weakness was associated with greater CSSs, slower velocities in timed function tests, and lower MMT scores (p < 0.05). CONCLUSION: Significant clinical variability was observed in early-onset FSHD. Earlier age at onset of facial weakness was associated with greater disease severity. Longitudinal assessments are needed to determine the rate of disease progression in this population.
引用
- Mah JK, Feng J, Jacobs MB, et al. A multinational study on motor function in early-onset FSHD. Neurology. 2018. PMID: 29540582. doi:10.1212/WNL.0000000000005297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。